OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 01, 2014
A changing biopharmaceutical industry is going beyond typically outsourced activities and is using CMOs for more challenging processes. Review the top 10 outsourcing trends.
For a drug-development process that relies on outsourced services, special considerations are needed to ensure the proper transfer of technology and information from one phase to the next.
January 31, 2014
PharmaCell enters an agreement purchase TiGenix therapy production facility.
Regis Technologies passes a recent FDA audit with no Form 483 observations.
With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.
January 02, 2014
The R&D model is in transition and creating new demands on contract services providers.
Roger Hayes of MPI Research discusses highly potent drug development.
December 02, 2013
Siegfried Schmitt, principal consultant at PAREXEL, discusses the state of drug manufacturing in India.
Ongoing changes create new opportunities for CROs and CMOs.
Brian Galliher of Cook Pharmica discusses visual inspection systems.